中文别名:
紫草酸B;丹酚酸 B;丹酚酸 B, 来源于丹参;丹酚酸B、丹参酸B、丹参酸乙、紫草酸B;丹酚酸B USP标准品;(R)-2-(((2S,3S)-4-((E)-3-((R)-1-羧基-2-(3,4-二羟基苯基)乙氧基)-3-氧代丙-1-烯-1-基)-2-(3,4-二羟基苯基)-7-羟基-2,3-二氢苯并呋喃-3-羰基)氧基)-3-(3,4-二羟基苯基)丙酸;化合物LITHOSPERMIC ACID B;(R)-2-(((2S,3S)-4-((E)-3-((R)-1-羧基-2-(3,4-二羟基苯基)乙氧基)-3-氧代丙-1-烯-1-基)-2-(3,4-二羟基苯基)-7-羟基-2,3-二氢苯并呋喃-3-羰基)氧基)-3-(3,4-二羟基苯基)
英文名称:
lithospermic acid B
英文别名:
3-(1-Carboxy-2-(3,4-dihydroxyphenyl)ethyl) 4-(3-(1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propenyl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylate (2S-(2alpha,3beta(S*),4(E(S*))))-;3-Benzofurancarboxylic acid, 4-(3-(1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propenyl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-, 3-(1-carboxy-2-(3,4-dihydroxyphenyl)ethyl) ester, (2S-(2alpha,3beta(S*),4(E(S*))))-;Salvialic acid B;Lithospermic acid B;Danfensuan B;SALVIANOLIC ACID B;LITHOSPERMIC ACID B;DANFENSUAN B;Extra Cas No: 115939-25-8;(2S,3S)-4-[(1E)-3-[(1R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylic acid 3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl] ester
InChI:
InChI=1/C36H30O16/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48)/b10-5+/t27-,28-,31+,32-/m1/s1
密度:
1.637±0.06 g/cm3(Predicted)
沸点:
1020.3±65.0 °C(Predicted)
物化性质:
来源于唇形科植物丹参(Savia miltiorrhiza)
产品用途:
用于含量测定/鉴定/药理实验等。
药理药效:自由基清除剂。本品具有活血化瘀,通经活络之功效,主治因瘀血阻滞经络所致缺血性中风,症见半身肢体麻木,虚弱无力,拘挛疼痛,或运动不遂,口眼歪斜等。